��ƷSM����ӰƬ

With this technology, once accessible only to professional scientists but now free to all, researchers can remotely use ��ƷSM����ӰƬ startup ColdQuanta’s quantum-matter machine to design potentially transformative innovations.

Vitro3D, a ��ƷSM����ӰƬ startup pioneering volumetric 3D printing for life sciences, just closed its first investment round of $1.3 million. The hard-won vote of confidence from the investment community will allow the promising new venture to pursue ambitious technical advances while continuing to build critical business capacity. 

ColdQuanta, a ��ƷSM����ӰƬ spinout and the global quantum ecosystem leader, announced a $110 million Series B round of funding to continue commercializing the company’s product portfolio, including quantum computing, quantum algorithms and applications, atomic clocks, sensors and components.

Arpeggio’s technology isolates a drug’s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors. Funding was led by Builders VC and will support ongoing development of Arpeggio’s drug pipeline as well as its transcription-monitoring technologies.

This year’s Top Company winners and finalists represent 13 industry categories. Entrants were judged on three criteria: outstanding achievement, financial performance and community involvement. ColdQuanta won in the "Technology, Software & Communications" category.

It's hard to find a physics or chemistry teacher that doesn't use PhET Interactive Simulations, a free online science and math simulations platform founded at ��ƷSM����ӰƬ in 2002 by Nobel Laureate Carl Wieman. These beautifully designed STEM explorations are loved by students and educators alike.

Keith “Bang Bang” McCurdy is taking HYPRSKN—the microscopic skin implants with adaptive, color-changing in-skin pigments developed by Carson Bruns and Jesse Butterfield of ��ƷSM����ӰƬ's ATLAS Institute—to the next level with real tattoo ink that you can “turn on” or off using different wavelengths of UV and white light.

The merger is addressing pressing needs in quantum research for ��ƷSM����ӰƬ spinout ColdQuanta—as well as the quantum industry. Both companies are affiliates of Q-NEXT, a U.S. Department of Energy (DOE) National Quantum Information Science Research Center led by Argonne National Laboratory.

Think Bioscience (“Think”), a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, has raised $17M in an oversubscribed Seed round. Think's foundational IP was developed by CEO Jerome Fox's research group at ��ƷSM����ӰƬ.

“For the industry, now is the time to solve this problem,” Wil Srubar, an associate professor at ��ƷSM����ӰƬ and the lead researcher on the project, says in a news release. “We believe that we have one of the best solutions, if not the best solution, for the cement and concrete industry to address its carbon problem.”